泰格莎對EGFR突變晚期肺癌的無惡化存活時間影響Impact of Osimertinib on Progression-Free Survival in EGFR-Mutated NSCLC

Name: 泰格莎對EGFR突變晚期肺癌的無惡化存活時間影響Impact of Osimertinib on Progression-Free Survival in EGFR-Mutated NSCLC
Uploaded: 2026-02-16T00:25:46.126Z
Duration: 6 min 5 s
Channel: 腫瘤科吳教恩醫師
Description: 晚期肺癌 泰格莎 第一線治療的效果如何？